| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aeon Biopharma, Inc. (AEON) has 9 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. AEON is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 2.18M | $1.82M | - | |
| VP | 1.32M | $1.10M | - | |
| Other | 925.9K | $772.2K | - | |
| Dir | 370.4K | $308.9K | - | |
| Dir | 308.6K | $257.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 21, 2025 | Fischer Jost63 | Director | Buy | 60,000 | $0.49 | $29,250.00 | +29.0% | +50.4% | - | |
| May 20, 2025 | Fischer Jost63 | Director | Buy | 110,000 | $0.50 | $55,300.00 | +45.2% | +48.4% | - |